These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26380097)

  • 21. Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation.
    Borghi C; Bacchelli S; Esposti DD; Bignamini A; Magnani B; Ambrosioni E
    Am J Hypertens; 1999 Jul; 12(7):665-72. PubMed ID: 10411363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum cholesterol levels on admission and survival in patients with acute myocardial infarction treated with zofenopril: a post hoc analysis of the Survival of Myocardial Infarction Long-term Evaluation trial.
    Borghi C; Cicero AF; Bacchelli S; Esposti DD; Ambrosioni E;
    Fundam Clin Pharmacol; 2009 Oct; 23(5):641-8. PubMed ID: 19656211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
    Ambrosioni E; Borghi C; Magnani B
    Am J Cardiol; 1991 Nov; 68(14):101D-110D. PubMed ID: 1746414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A review of the angiotensin-converting enzyme inhibitor, zofenopril, in the treatment of cardiovascular diseases.
    Borghi C; Bacchelli S; Degli Esposti D; Ambrosioni E
    Expert Opin Pharmacother; 2004 Sep; 5(9):1965-77. PubMed ID: 15330734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zofenopril versus ramipril in the early phase of acute myocardial infarction with systolic dysfunction: A retrospective study.
    Liu X; Xu X; Chu Y; Ren Y; Wang L
    J Renin Angiotensin Aldosterone Syst; 2020; 21(3):1470320320946530. PubMed ID: 32883157
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the ACE inhibitor zofenopril in the treatment of ischemic heart disease.
    Buikema H
    Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):631-47. PubMed ID: 17081085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-Converting Enzyme Inhibition: Beyond Blood Pressure Control-The Role of Zofenopril.
    Borghi C; Omboni S
    Adv Ther; 2020 Oct; 37(10):4068-4085. PubMed ID: 32770530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the early ACE inhibition in diabetic nonthrombolyzed patients with anterior acute myocardial infarction.
    Borghi C; Bacchelli S; Esposti DD; Ambrosioni E;
    Diabetes Care; 2003 Jun; 26(6):1862-8. PubMed ID: 12766124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of early angiotensin-converting enzyme inhibition in patients with non-ST-elevation acute anterior myocardial infarction.
    Borghi C; Bacchelli S; Degli Esposti D; Ambrosioni E;
    Am Heart J; 2006 Sep; 152(3):470-7. PubMed ID: 16923416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy of ACE-inhibitors in patients with recent myocardial infarction. Studies with zofenopril].
    Lombardi C; Castrini AI; Metra M; Carubelli V; Lazzarini V; Inama L; Dei Cas L
    G Ital Cardiol (Rome); 2012 Oct; 13(10 Suppl 2):55S-58S. PubMed ID: 23096377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The SMILE study: the rationale, design, organization and definition of the objectives. Survival of Myocardial Infarction Long-term Evaluation].
    Ambrosioni E; Borghi C; Magnani B
    Ann Ital Med Int; 1993; 8(4):230-4. PubMed ID: 8161479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term clinical experience with zofenopril.
    Borghi C; Bacchelli S; Degli Esposti D
    Expert Rev Cardiovasc Ther; 2012 Aug; 10(8):973-82. PubMed ID: 23030285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction.
    Goa KL; Balfour JA; Zuanetti G
    Drugs; 1996 Oct; 52(4):564-88. PubMed ID: 8891468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
    van Wijngaarden J; Pinto YM; van Gilst WH; de Graeff PA; de Langen CD; Wesseling H
    Cardiovasc Res; 1991 Nov; 25(11):936-42. PubMed ID: 1813122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining the role of zofenopril in the management of hypertension and ischemic heart disorders.
    Ambrosioni E
    Am J Cardiovasc Drugs; 2007; 7(1):17-24. PubMed ID: 17355163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zofenopril versus Lisinopril in the Treatment of Essential Hypertension in Elderly Patients : A Randomised, Double-Blind, Multicentre Study.
    Malacco E; Piazza S; Omboni S;
    Clin Drug Investig; 2005; 25(3):175-82. PubMed ID: 17523766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Zofenopril and incidence of cough: a review of published and unpublished data.
    Omboni S; Borghi C
    Ther Clin Risk Manag; 2011; 7():459-71. PubMed ID: 22162922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers.
    Lavorini F; Chellini E; Innocenti M; Campi G; Egan CG; Mogavero S; Fontana GA
    Cough; 2014; 10(1):7. PubMed ID: 25632296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.